Evolution of the Average Target: Protalix BioTherapeutics, Inc.

Evolution of the Average Target - Protalix BioTherapeutics, Inc.

Evolution of the Target Price: Protalix BioTherapeutics, Inc.

Evolution of the Target Price - Protalix BioTherapeutics, Inc.

Changes in Analyst Recommendations: Protalix BioTherapeutics, Inc.

e33da0a69fba131e.L2eaxUXnqt8wjIAmXgp0kKp76ERQ2Md1Q30ogg4wWLU.fR3jgzyiwJ57v8tqbUQZ95s3mDA5l68GF09-6HtlKOp7E_P8K6PGhkn99w~d85675e25f09936fd43e9cc1b60c6e94

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +293.44%
+1.38%
-2.22%
+5.69%
-2.05%
+9.32%
-3.71%
+16.57%
-7.27%
+3.98%
Average +31.51%
Weighted average by Cap. +1.98%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.050USD
Average target price
12.00USD
Spread / Average Target
+293.44%
High Price Target
12.00USD
Spread / Highest target
+293.44%
Low Price Target
12.00USD
Spread / Lowest Target
+293.44%

Analyst Consensus Detail

Analyst consensus - Protalix BioTherapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Protalix BioTherapeutics, Inc.
  1. Stock Market
  2. Stocks
  3. PLX Stock
  4. Consensus Protalix BioTherapeutics, Inc.